APELLIS PHARMACEUTICALS INC (APLS)

US03753U1060 - Common Stock

49.93  +1.21 (+2.48%)

After market: 48.1716 -1.76 (-3.52%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
396.59M75.40M66.60M250.60M0.00
Cost Of Goods
58.51M5.60M5.20M25.10MN/A
Gross Profit
338.08M69.80M61.40M225.60MN/A
Operating Expenses
855.20M664.40M597.60M439.30M288.00M
Research and Development
354.39M387.20M420.90M299.90M221.00M
Selling, General, and Administrative Expenses
500.81M277.20M176.80M139.40M67.00M
Operating Income
-517.12M-594.60M-536.30M-213.70M-288.00M
Interest Income/Expense
-8.65M-23.70M-110.50M-128.80M-15.00M
Other Income/Expense
-727.00K-300.00K1.40M-500.00K-200.00K
Non Recurring Items
0.00-32.90M-100.60MN/A-1.50M
Income Before Taxes
-526.50M-651.50M-746.00M-343.00M-304.70M
Income Tax
2.13M700.00K400.00K1.80MN/A
Net Income
-528.63M-652.20M-746.40M-344.90M-304.70M
EBITDA
-515.34M-593.05M-534.92M-213.06M-287.76M
 
Per Share Data
EPS Diluted Total Ops
-4.45-6.15-8.84-4.59-4.90
Non GAAP EPS
-4.48-6.13-8.93-4.72-4.86
 
Statistics
Gross Profit Margin
85.25%92.57%92.19%90.02%N/A
Profit Margin
-133.29%-864.99%-1120.72%-137.63%N/A
Operating Profit Margin
-130.39%-788.59%-805.26%-85.28%N/A

All data in USD

Charts